A Lyme disease vaccine from Pfizer and Valneva is in a Phase 3 trial right now. We’re hopeful that the vaccine will be ready in 2025. The UMass Chan Medical School is also studying another potential therapy to prevent Lyme disease that is in clinical trials. This prevention is not a vaccine but a monoclonal antibody that kills the Lyme bacteria in the tick’s gut.
This is good news. I like the idea of the monoclonal antibody. What potential side effects for humans?
This is good news. I like the idea of the monoclonal antibody. What potential side effects for humans?